Caerus Molecular Diagnostics

The Mountain View, California-based startup is working on proof of concept for the method, which relies on the release of an activator from dNTP that switches on an enzyme.

Companies developing DNA sequencing and related technologies, as well as firms working on sequencing-based genetic tests, were among almost 3,000 small biotechs who received a total of $1 billion in grants and tax credits under the QTDP program.

Several grantees are affiliated with companies working on new commercial sequencing technologies, including GnuBio, Caerus Molecular Diagnostics, Oxford Nanopore Technologies, Intelligent Bio-Systems, NobleGen Biosciences, and Halcyon Molecular.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.